Name | Value |
---|---|
Revenues | 5,443.0K |
Cost of Revenue | 888.0K |
Gross Profit | 4,555.0K |
Operating Expense | 8,404.0K |
Operating I/L | -3,849.0K |
Other Income/Expense | 221.0K |
Interest Income | 225.0K |
Pretax | -3,628.0K |
Income Tax Expense | -122.0K |
Net Income/Loss | -3,506.0K |
electroCore, Inc. is a commercial stage medical device company specializing in non-invasive vagus nerve stimulation (nVNS) therapies. Their flagship product, gammaCore Sapphire, is a prescription-only nVNS therapy designed for the acute treatment of pain associated with migraine and episodic cluster headache in adults. The device is rechargeable and reloadable, offering regular or intermittent use over many years. The company generates revenue through the development and commercialization of nVNS therapies, providing a non-invasive treatment option for patients suffering from these conditions.